Method for nicotine-based product users to reduce or eliminate use of nicotine-based products

A nicotine-free inhalation device with glycerin/propylene glycol and pleasant flavors effectively reduces nicotine use by providing sensory distraction, achieving high cessation rates and withdrawal symptom relief.

US20260354453A1Pending Publication Date: 2026-11-12INHALE HEALTH LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
US19/659266
Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
Priority Date
2020-09-09
Filing Date
2026-04-27
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing nicotine cessation aids rely on nicotine delivery or harsh irritants to simulate smoking, failing to provide effective and pleasant sensory experiences that help users quit or reduce nicotine consumption.

Method used

A nicotine-free inhalation device using a glycerin/propylene glycol base with pleasant flavors like mango, apple, mint, or peach to deliver sensory distraction and reduce cravings.

Benefits of technology

The device significantly reduces or eliminates nicotine use by engaging users with enjoyable flavors, achieving high cessation rates and withdrawal symptom relief, outperforming traditional methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US20260354453A1-D00000_ABST
    Figure US20260354453A1-D00000_ABST
Patent Text Reader

Abstract

A method for by a nicotine-based product user to reduce or eliminate nicotine-based product consumption includes: providing an inhalation device having a) an inhaler having the functional components of a vape inhaler, including an inhaler nozzle, an air intake portal, a vapor generator mechanism, and a reservoir for material to be vaporized and inhaled; and b) material to be vaporized and inhaled, contained within the reservoir, the material including the following required constituents; i) glycerin, ii) propylene glycol, and iii) one or more flavorants selected for its pleasant characteristics selected from the group consisting of aroma, taste and combinations thereof, the material being nicotine-free; and having the user activate the inhaler device and inhale vaporized nicotine-free formulation of the glycerin, propylene glycol and at least one the flavorant.
Need to check novelty before this filing date? Find Prior Art

Description

REFERENCE TO RELATED APPLICATIONS

[0001] This application is a continuation in part of co-pending U.S. patent application Ser. No. 18 / 044,563 filed on Mar. 8, 2023 by inventor Daniel Frederick Woolf Shapiro, titled “Nicotine-Free Formulations, Devices and Methods Thereof For Cessation of Smoking or Nicotine Replacement” which itself has priority based on PCT Application PCT / US 2021 / 049728 filed on Sep. 9, 2021 of the same inventor and title, and which claims priority based on U.S. Provisional Application No. 63 / 076,344 filed on Sep. 9, 2020.INCORPORATION BY REFERENCE

[0002] The parent application cited above, namely, co-pending U.S. patent application Ser. No. 18 / 044,563 filed on Mar. 8, 2023 by inventor Daniel Frederick Woolf Shapiro, titled “Nicotine-Free Formulations, Devices and Methods Thereof For Cessation of Smoking or Nicotine Replacement” is incorporated herein by reference in its entirety.BACKGROUND OF INVENTIONa. Field of Invention

[0003] The present invention relates generally to the problem of nicotine usage and addiction resulting from smoking cigarettes, cigars, vapes and chew. Specifically, people who smoke nicotine-based products, such as cigarettes, cigars, vapes, nicotine oral pouches, and / or use nicotine-based chewing products (commonly referred to as “chew”), become addicted to those products due to the addictive nature of nicotine. The results are obvious in today's society-health deterioration, cancer, shortness of life, emphysema, other related diseases, COPD, diversion / waste of personal finances, social embarrassment, etc. Most people who consume nicotine-based products tell the world that they enjoy using them, but in their hearts, they know that they want to quit; they know that they should quit for many reasons, yet they cannot quit because the nicotine craving is too strong. In the incorporated by reference parent case cited above, various studies are shown to support the problem that a growing percentage of very young adults are taking up vape smoking, reversing the previously decreasing percentage of nicotine users prior to the emergence of the now very significant vape market.

[0004] The present invention is a method for users of nicotine products to reduce or eliminate usage of those products. The present invention methods use devices that may be employed to replace all the aforesaid nicotine-based products to reduce or completely eliminate the need for such products. More specifically, the present invention is a method that includes providing a user with an inhaler device that has a conventional vape-like “burner” and has unique components that have been scientifically shown to reduce or eliminate nicotine consumption. The present invention method employs devices that include an inhaler, a base consuming constituent of two specific ingredients, and a flavoring component selected from a narrow group of flavorants that function as pleasant distractants.b. Description of Related Art

[0005] Conventional smoking-cessation aids focus on delivering nicotine or simulating tobacco harshness. For example, Jed E. Rose co-invented the nicotine patch and patented nicotine-delivery aerosols to help smokers and vapers quit. Other devices provide cigarette-like sensations: U.S. Pat. No. 6,041,789 (Brankert et al.) teaches a “cigarette substitute” with volatile nicotine-mimetic compounds and added flavor agents to mask their unpleasant taste. U.S. Pat. No. 5,893,371 (Rose & Behm) even uses pepper-derived irritants (capsaicin, piperine) to mimic smoke sensations and suppress cravings. These prior designs explicitly aim to reproduce the harsh or aversive aspects of smoking (through nicotine agonists or spicy irritants) rather than provide inherently pleasant sensory experiences.

[0006] United States Patent Publication No. 2018 / 0338905 to an inventor herein, namely Shapiro, and to others, describes methods of preparing inhalable supplements. The methods involve aerosolizing a liquid comprising a carrier and a dietary nutrient or vitamin supplement by heating the liquid to a temperature that retains the bioavailability of the supplement. Suitable carriers include, but are not limited to glycerin, such as vegetable glycerin, 1,2-propanediol, 1,3-propanediol, and combinations thereof. In an embodiment, the carrier comprises a mixture of glycerin, 1,2-propanediol, and 1,3-propanediol. In an embodiment, the carrier comprises a mixture of glycerin and 1,3-propanediol. In an embodiment, the carrier comprises a mixture of glycerin and 1,2-propanediol. In an embodiment, the carrier comprises a mixture of 1,2-propanediol and 1,3-propanediol. In some embodiments, the carrier comprises glycerin and 1,3-propanediol present in a weight ratio of 1:1000 to 1000:1. In some embodiments, the carrier comprises glycerin and 1,2-propanediol present in a weight ratio of 1:1000 to 1000:1. Suitable supplements include, but are not limited to, vitamin B1, vitamin B2, vitamin B6, vitamin B12, ascorbic acid, biotin, melatonin, L-theanine, caffeine, and combinations thereof. In an embodiment, the inhalable supplement comprises vitamin B1, vitamin B2, vitamin B6, vitamin B12, ascorbic acid, biotin, or combinations thereof. In an embodiment, the inhalable supplement comprises vitamin B12. In an embodiment, the inhalable supplement comprises a mixture of vitamin B1, vitamin B2, vitamin B6, and vitamin B12. In an embodiment, the inhalable supplement comprises ascorbic acid. In an embodiment, the inhalable supplement comprises biotin. In an embodiment, the inhalable supplement comprises melatonin. In an embodiment, the inhalable supplement comprises L-theanine. In an embodiment, the inhalable supplement comprises caffeine. In an embodiment, the inhalable supplement comprises a mixture of L-theanine and caffeine.

[0007] United States Patent Publication No. 2012 / 0128744 to Sorge et al describes 1-menthol and optionally additionally 1-menthol-containing mixtures, which are liquid at normal pressure and a temperature of 20 degrees C or higher. This invention further relates to products that comprise such a mixture or that are preparable by mixing or contacting such a mixture with further ingredients, and novel processes for preparing menthol-containing products. In particular owing to its excellent property of producing a refreshing sensation of coolness on the skin and mucosae, the flavoring material menthol is among the most important substances used for flavoring products, in particular dental hygiene products, chewing gums and refreshing sweets.

[0008] United States Patent Publication No. 2019 / 0054257 to Cameron et al describes an electronic vapor device including: a device processor operable for controlling the electronic vapor device; a container configured to store a vaporizable material; a vaporizing component, wherein the vaporizing component is in fluid communication with the container for receiving a selected amount of vaporizable material therefrom; at least one sensing component, wherein the at least one sensing component is configured to detect a plurality of status data associated with the vaporizable material; and wherein the device processor is further operable to: receive at least a portion of the detected status data from the at least one sensing component; determine at least one vaporizing configuration for vaporizing at least a portion of the vaporizable material received in the vaporizing component, and generate at least one vaporizing control signal for controlling at least one operational parameter of the electronic vapor device in accordance with the at least vaporizing configuration.

[0009] United States Patent Publication No. 2015 / 0283070 to Stenzler et al discloses a dry powder nicotine formulation suitable for inhalation. The formulation includes nicotine particles, wherein the nicotine particles are substantially in the range of about 1-10 micron in size, preferably 2-5 micron in size. The formulation may also include a cough suppressant component having particles in the 5-100 micron size range. The formulation may also include a cough suppressant component having particles in the 10-200 micron size range. The formulation may also include a flavor component having particles in the 10-1000 micron size range.

[0010] United States Patent Publication No. 2015 / 0257447 to Sullivan describes devices, components, and conduit assemblies for delivery of a breathable / inhalable fluid stream containing a solvation-enhancing atomized liquid, the fluid stream carrying a functional liquid component. In one aspect, devices of the invention incorporate an exchangeable fluid-permeable body, such as a cartridge comprising a fluid-permeable packing material, containing the functional liquid. In another aspect, devices of the invention incorporate an electronic control system configured to detect and store physical states, settings, modes / configurations, and / or usage of the device over time. Optionally, the detected states may be exported to a separate electronic device via a Wi-Fi or other suitable remote connection. In other embodiments, the electronic control system provides passcode authorization for actuating an atomizing element and / or toggling the device between locked and unlocked states.

[0011] US Patent Publication no. US 2020 / 0107578 A1 to Darren Rubin (application Ser. No. 16 / 709,555, Date Filed 2019 Dec. 10) discusses vaporizers and e-cigarettes in the context of flavor elements, and references vape nicotine-free e-cigarettes. This reference also notes that propylene glycol and glycerine (glycerin) help form an aerosol, meaning, the combination is used in e-cigarettes with dried tobacco. It also describes flavoring with mint, mango and other fruit flavors. However, this reference describes non-vaporized flavor elements and thus its sensory ability is inhibited and different. This reference states at paragraph

[0004] : “By providing nonvaporized flavor element(s) to the electronic vaporizer and user, especially of non-tobacco or non-menthol flavor, the disclosed methods can provide the candy, fruit, or mint flavor that vapers desire without vaporizing the flavor substance. The embodiments presented herein may prevent e-cigarette users from switching back to cigarettes or flavored cigars (e.g., combustible products). The embodiments presented herein may also help e-cigarette users reduce their nicotine intake, without necessarily reducing vaping. This can be done by helping e-cigarette users gradually vape products with lower and lower nicotine content, and possibly even eventually vape nicotine-free e-cigarette products.” And at paragraph

[0014] “One type of electronic vaporizer appears like a cigarette warmer. While not believed to accept standard cigarettes, these warming devices accept a modified cigarette, rather a cigarette-like stick (or heat stick) that contains dried tobacco leaves and other ingredients, such as propylene glycol and glycerin, which help form an aerosol.”

[0012] Notwithstanding the prior art, the present invention is neither taught nor rendered obvious thereby.SUMMARY OF THE INVENTION

[0013] The present invention is a method for use by a nicotine-based product user to reduce or eliminate nicotine-based product consumption, which includes providing the user with an inhalation device a) an inhaler having the functional components of a vape inhaler, including and inhaler nozzle, an air intake portal, a vapor generator mechanism, and a reservoir for material to be vaporized and inhaled; and, b) material to be vaporized and inhaled, contained within said reservoir, said material including the following required constituents; i) glycerin, ii) propylene glycol, and iii) one or more flavorants selected for its pleasant characteristics selected from the group consisting of aroma, taste and combinations thereof, said material being nicotine-free, and having said user activate said inhaler device and inhale vaporized nicotine-free formulation of said glycerin, propylene glycol and at least one said flavorant.

[0014] In preferred embodiments, one or more flavorants are one or more natural, synthetic or mixed natural and synthetic flavorants selected from the group consisting of mango, mint, apple, peach and non-nicotine tobacco.

[0015] In some embodiments, the present invention method has an inhalation device vapor generator mechanism that is selected from the group consisting of a thermal vapor generator mechanism and a mechanical vapor generator mechanism, and said reservoir is a removable, replaceable cartridge. Alternatively, the reservoir may be a permanent (non-cartridge) component of the device. In some embodiments, the vapor generator mechanism is selected from the group consisting of a thermal vapor generator mechanism and a mechanical vapor generator mechanism. In some of these embodiments, vapor generator mechanism is a thermal vapor generator mechanism that includes a heating disc and a power source and an on-off control for activating and deactivating said heating disc. In others, vapor generator mechanism is a thermal vapor generator mechanism that includes a heating element (such as a coil) and a power source and an on-off control for activating and deactivating said heating element. In some embodiments, the power source is a rechargeable battery and in others, it is a disposable battery.

[0016] In some embodiments, the vapor generator mechanism rechargeable battery power source has a charging module, e.g., an electrical recharging port (such as a USB port or equivalent) and also has a connected signal light indicator that illuminates when the battery is fully charged, such as an LED signal light.

[0017] In an alternative embodiment, the vapor generator mechanism is a mechanical vapor generator mechanism that includes a nebulizer mechanism. In yet other embodiments, any known vape device may be used with the present invention reservoir with the essential components (required constituents). The essential components are the aforesaid materials in said reservoir, namely, said material including the following required constituents; i) glycerin, ii) propylene glycol, and iii) one or more flavorants selected for its pleasant characteristics selected from the group consisting of aroma, taste and combinations thereof, said material being nicotine-free.

[0018] In general, the quantities of required constituents should be a mixture of these constituents in amounts that achieve effective functionality as to reducing or eliminating the use of nicotine products by a user, i.e., amounts necessary to achieve good to excellent efficacy. Thus, broadly, a therapeutically effective amount of each is employed. In some embodiments, the required constituents include 10% to 79.9% by weight of glycerin based on 100% by weight of all required constituents; 20% to 89.9% by weight of propylene glycol based on 100% by weight of all required constituents; and 0.1% to 60% by weight of flavorants based on 100% by weight of all required constituents. Preferred ranges of these required constituents are: 35% to 75% by weight of glycerin based on 100% by weight of all required constituents; 30% to 70% by weight of propylene glycol based on 100% by weight of all required constituents and 1% to 25% of one or more flavorants by weight, based on the total weight of the required constituents. In some embodiments, there are additional components. Thus, the present invention inhalation device reservoir further includes one or more botanical extracts selected from the group consisting of menthol, limonene and linalool. Alternatively, or in addition to the aforesaid botanical extracts, the reservoir further includes one or more bioactive additives selected from the group consisting of L-theanine, melatonin, caffeine and ascorbic acid.BRIEF DESCRIPTION OF THE DRAWINGS

[0019] FIG. 1-A illustrates a block diagram of the features of the present invention method using the unique inhaler device, FIG. 1-B shows the basic features of the device used in the present invention method, and FIG. 2 illustrates a second device block diagram showing more details and options of the present invention method inhalation device;

[0020] FIGS. 3 and 4 show different views of a specific example of a present invention method with the nicotine-free inhalation device;

[0021] FIG. 5 shows a bar diagram of results from a survey as to how long a group of test users had used the present invention method with the non-nicotine inhalation device;

[0022] FIG. 6 shows a bar diagram of results from a survey as to what percentage of the present invention non-nicotine inhalation method and device usage replaced nicotine smoking and / or nicotine vaping;

[0023] FIG. 7 shows a bar diagram of results from a survey as to relative effectiveness of the present invention non-nicotine present invention method versus other therapies;

[0024] FIG. 8 shows a bar diagram of results from a survey as to whether the present invention non-nicotine inhalation method usage has helped to reduce nicotine smoking or vaping;

[0025] FIG. 9 shows a bar diagram of results from a survey as to whether the present invention non-nicotine inhalation method has helped in social smoking situations;

[0026] FIG. 10 shows a bar diagram of results from a survey as to what percentage of the present invention non-nicotine inhalation method and device users prefer each offered flavor; and

[0027] FIG. 11 shows a bar diagram of results from a survey as to what percentage of the present invention non-nicotine inhalation method replaced nicotine smoking and / or nicotine vaping.DETAILED DESCRIPTION OF THE PRESENT INVENTION

[0028] The present invention is a nicotine-free method, using an electronic vaporizer device that uses inherently pleasant, non-aversive flavors (i. e. mango, apple, mint, peach and non-nico tobacco) in a glycerin / propylene glycol base as “sensory distractants” to help smokers and vapers reduce or quit nicotine use. Unlike prior approaches that rely on nicotine delivery or harsh irritants to simulate smoking, this invention method relies solely on flavorful vapor to occupy sensory cues and cravings. Consumer feedback indicates that many users significantly reduce or even stop smoking when using this method with the unique nicotine-free device. In one embodiment, the present invention method uses a handheld rechargeable device that heats a glycerin / PG liquid containing natural fruit and mint flavor extracts (with no nicotine), producing a smooth, pleasant vapor. The invention thus provides unexpected craving relief and smoking and nicotine vaping reduction through enjoyable flavors, an effect supported by user surveys discussed in detail below.

[0029] The present invention provides a method with a nicotine-free vaping device whose primary cessation mechanism is sensory distraction via selected flavors. More specifically, the present invention method device includes a glycerin / propylene glycol liquid reservoir (common e-liquid base) enriched with one or more natural flavor compounds selected from mango, apple, mint, or peach or non-nicotine tobacco, the last included due to the familiarity of flavor to the user. More preferred is the flavorant selected from mango, apple, mint, or peach. These flavors are chosen to be smooth and pleasing, not bitter or irritating. A heating element (coil) or disc vaporizes the flavored liquid upon inhalation, delivering flavorful vapor to the user. Because there is no nicotine (or nicotinomimetic) present, the vapor causes no pharmacological addiction, but the rich sensory input reduces cravings for cigarettes or vapes by substituting enjoyable taste and smell cues.

[0030] Some of the important advantages of the invention include: Pleasant sensory cues: The vapor's sweet / fruit / menthol flavors actively engage the palate and olfaction, serving as “sensory distractants” to smoking urges. This is counter to prior methods and devices using unpleasant additives. Nicotine-free: No nicotine or nicotine-containing components are used, so the user's body remains free of tobacco alkaloids and nicotine. Proven reduction effect: In consumer trials (surveys discussed below), a large majority of users reported that the flavored devices significantly cut down their cigarette / vape use, and roughly one-third reported quitting entirely after use. This unexpected result supports the non-obvious effectiveness of the approach. Simple, safe composition: The liquid base (glycerin / propylene glycol) and food-grade flavorants are well-known, non-toxic substances. The device is preferably rechargeable and uses standard components (battery, heater, air channels) familiar from e-cigarette technology. In contrast to prior art devices (e.g., U.S. Pat. Nos. 6,041,789 and 5,893,371) that either deliver nicotine or add irritating stimuli, the present invention relies solely on positive sensory experience to help smokers and vapers quit. This approach, supported by experts in smoking cessation, is novel and yields unexpectedly high cessation rates.

[0031] FIG. 1-A illustrates a block diagram of the features of the present invention Method, block 10. Blocks 12, 14, 16, 18 and 20 illustrate the steps and device and necessary and optional materials used in the reservoir. The method uses the inhaler device of FIG. 1, block 1, and FIG. 2 illustrates a block diagram showing more details and options of the present invention method inhalation device, block 11. FIG. 1-B reiterates the invention, block 1, by setting out the invention components via blocks 3, 5, 7, and 9 taken from the Summary set forth above. FIG. 2 reiterates the details of the present invention, block 11, by setting out the details of the present invention components via blocks 13, 15, 17, 19, 21 and 23, as taken from the Summary set forth above.

[0032] FIGS. 3 and 4 show different views of a specific example of a present invention inhalation method device 50. Identical parts are identically numbered in both FIGS. 3 (side view) and 4 (top view). Present invention method device 50 includes a main housing 51 that here is an elongated main housing. There is also an anterior component 53 that includes a mouthpiece 55 for inhalation, a reservoir 57 for the material to be vaporized and inhaled, and a mesh coil heating element 59. In this embodiment, anterior component 53 may be permanently attached to main housing 51, in which case, the reservoir becomes permanent, or anterior component 53 may be removably and irreplaceably attached so that reservoir 57 acts as a replaceable cartridge. The reservoir 57 contains the essential constituents described (one or more of the selected flavorants, glycerin, and propylene glycol, and possible optional additives discussed above).

[0033] The main housing 51 is shown exposed (cut view) in FIG. 3 but not exposed in FIG. 4. In FIG. 3, main housing 51 shows a charging system, such as a wireless charger or has a port, such as a USB port 53 for connecting to power for charging rechargeable battery 65. There are one or more air intake portals, such as portal 75. There is an activation switch 67, which, when depressed, sends power to the heating element 59 via wring 69 and 71 for a preset time to release (vaporize) a puff of inhalant for the user. In preferred embodiments, there is a PCB control board 77 that may include sensors, timer, wireless transmission of user activity data, as well as charging and charged signals to LEDs 73 and display to a small screen (not shown). Thus, a user may partake of the nicotine-free, pleasant inhalants to reduce or eliminate the desire and use of nicotine-containing products. Thus, when a user depresses activator 67, element 65 immediately heats and when the user draws (inhales) content by sucking on anterior component mouthpiece 55, vaporized flavor is delivered for the pleasure of the user.

[0034] The battery 65 is shown as rechargeable. Alternatively, this device may have a disposable (non-rechargeable) battery, and the entire device may be disposed away when the battery dies. In yet another embodiment, the device would be disposed of as soon as the reservoir contents were consumed.

[0035] In some embodiments, the device is a handheld vaporizer sized like a conventional e-cigarette. The exterior housing is preferably made of a durable plastic or metal alloy, such as with a matte finish for grip. Internally, the device contains a rechargeable battery (e.g., 400 mAh) and a resistive heating coil. A reservoir or wick assembly holds a liquid mixture of vegetable glycerin and propylene glycol (common e-cig bases) combined with flavor extracts. Critically, no nicotine or other tobacco alkaloids are present. The flavor additives are chosen from naturally derived flavor oils or essences, or synthetically derived flavor oils or essences, or combinations of both, and are inherently pleasant and palatable. When a user inhales through the mouthpiece, air is drawn across the heated coil, vaporizing the glycerin / PG mixture and entraining the flavor vapors into the inhaled aerosol. The result is a smooth, fragrant mist that the user breathes in, experiencing the taste and aroma of the chosen flavor. Because the flavors are sweet or fruity rather than bitter or harsh, the user's sensory receptors are engaged in a positive way. This pleasant sensory input serves as a distractor from nicotine cravings: the user's mouth, throat, and nose are occupied by enjoyable stimuli, reducing the psychological urge to smoke. Over time, repeated use was found to condition the smoker to associate inhalation behavior with these pleasant cues instead of nicotine delivery. The present invention method devices have structural features that include: Flavor Reservoir: A refillable or replaceable pod / cartridge filled with the glycerin / PG base plus flavor. This pod contains food-safe flavors (e.g., natural fruit essences) and may include dissolved botanical extracts (menthol from mint, limonene from citrus, etc.) to achieve the desired taste profile. Heating Element: A small coil or ceramic heater powered by the battery. It is calibrated to vaporize the liquid without combustion. The heating temperature is kept in the e-cigarette safe range (~200-250 °C) to avoid producing any unpleasant by-products. Airflow Path: Mouthpiece and internal channels direct inhaled air across the coil. Optionally, small LED indicators on the housing light up when the device is active to signal power status. A USB-C port on the base allows recharging of the battery. Importantly, the formulation is non-aversive: unlike some e-liquids that use bitter or spice ingredients, all flavor compounds here are selected for safety and sweetness. This can include pure fruit essences (mango extract, apple concentrate) and mint / menthol for a cool sensation. The pleasant nature of these flavors is essential: the invention diverges from conventional cessation aids by using enjoyment rather than discomfort as the quitting aid.

[0036] Consumer testing, discussed below, has shown that this approach works well. For purposes of the survey, tradenames were deployed, Anti-Cigarette being the present invention devices. In the Inhale Health survey, roughly 63% of users strongly agreed that the device helped them cut down on smoking or vaping, and about 32% reported that they had “successfully quit” smoking entirely after regular use of the device. These results highlight the non-obvious potency of flavor-based distraction: many individuals reduced or ceased nicotine use without any nicotine in the product.

[0037] The consumer testing survey referenced above was as follows: 114 smokers and vape users were engaged in the survey, approximately 29% females and 71% males. They were all adults over 21 years of age and more than 70% of these were 40 years of age or older. The group was approximately evenly divided among cigarette smokers and vape users (about 66% used cigarettes, 65% used vapes (with an overlap of some using both) and less than 5% were pouch or chew users.

[0038] Of those surveyed, over 58% smoked or vaped nicotine products for more than 10 years and another 14% for more than 5 years. Thus, note that almost 73% of those participating in the survey had smoked or vaped for at least 5 years and thus were characterized as habitual users. As to motivation, more than 90% indicated that they were extremely, very or moderately motivated to quit nicotine products, and about 65% were at least “very” motivated.

[0039] More than 60% of those surveyed woke up and reached for their nicotine product of choice within 30 minutes of waking. More than 80% had tried to stop using nicotine products in the past suffered withdrawal and were unsuccessful. The withdrawal symptoms included irritability, anger, nervousness and anxiety, sleep disturbances, hunger, restlessness, cravings and concentration difficulties. Over 40% of all participants had previously stopped the use of nicotine for at least six months yet returned to nicotine products thereafter. More than 40% of the cigarette smokers now smoked more than 10 cigarettes a day; more than 49% of the vape users was now consuming at least one full vape “pen” a day.

[0040] More than 80% of the participants indicated that they would use the present invention product to reduce smoking or vaping. Over 70% of the participants indicated that the present invention products helped them reduce or eliminate withdrawal symptoms including irritability, anger, nervousness and anxiety, sleep disturbances, hunger, restlessness, cravings and concentration difficulties. This was very unexpected.

[0041] FIG. 5 shows a bar diagram of results from the survey, as to how long a group of test users have used the present invention non-nicotine inhalation method / device, diagram 101 of FIG. 5. Table 1 below summarizes these results from 114 participants:TABLE 1HOW LONG A GROUP OF TEST USERS HAVEUSED THE PRESENT INVENTION NON-NICOTINEINHALATION METHOD / DEVICEANSWER CHOICESRESPONSESRESPONDENTSLess than one month16.67%19One to three months29.82%34Three to six months15.79%18Six months plus20.18%23More than one year17.54%20TOTAL114

[0042] FIG. 6 shows a bar diagram of results from a survey as to what percentage of the present invention non-nicotine inhalation method / device usage replaced nicotine smoking and / or nicotine vaping, diagram 102 of FIG. 6. Table 2 below summarizes these results:TABLE 2WHAT PERCENTAGE OF THE PRESENT INVENTION NON-NICOTINE INHALATION METHOD / DEVICE USAGE REPLACEDNICOTINE SMOKING AND / OR NICOTINE VAPINGANSWER CHOICESRESPONSESRESPONDENTSI use it more than 80% of all my42.11%48smoking / vaping per dayI use it about 50% of all of my20.18%23smoking / vaping per dayI use it less than 50% but more14.91%17than 25% of my smoking. vapingper dayI use it about 25% of the time7.02%8during the day for all mysmoking / vapingI use it rarely, less than 25%15.79%18of my daily smoking / vapingTOTAL114

[0043] FIG. 7 shows a bar diagram of results from a survey as to relative effectiveness of the present invention non-nicotine inhalation method / device versus other therapies, diagram 103 of FIG. 7. Table 3 below summarizes these results:TABLE 3RELATIVE EFFECTIVENESS OF THE PRESENTINVENTION NON-NICOTINE INHALATION METHOD / DEVICEVERSUS OTHER THERAPIESANSWER CHOICESRESPONSESRESPONDENTSVery Much agree53.51%61Moderately agree30.70%35Slightly agree10.53%12Disagree5.26%6TOTAL114

[0044] FIG. 8 shows a bar diagram of results from a survey as to whether the present invention non-nicotine inhalation method / device usage has helped to reduce nicotine smoking or vaping, diagram 104 of FIG. 8. Table 4 below summarizes these results:TABLE 4WHETHER THE PRESENT INVENTION NON-NICOTINEINHALATION METHOD / DEVICE USAGE HAS HELPEDTO REDUCE NICOTINE SMOKING OR VAPINGANSWER CHOICESRESPONSESRESPONDENTSVery Much agree63.16%72Moderately agree22.81%26Slightly agree12.28%14Disagree1.75%2TOTAL114

[0045] FIG. 9 shows a bar diagram of results from a survey as to whether the present invention non-nicotine inhalation method / device has helped in social smoking situations, diagram 105. Table 5 below summarizes these results:TABLE 5WHETHER THE PRESENT INVENTION NON-NICOTINE INHALATION DEVICE HAS HELPEDIN SOCIAL SMOKING SITUATIONSANSWER CHOICESRESPONSESRESPONDENTSVery Much agree56.14%64Moderately agree27.19%31Slightly agree12.28%14Disagree4.39%5TOTAL114

[0046] FIG. 10 shows a bar diagram of results from a survey as to what percentage of the present invention non-nicotine inhalation method / device users prefer each offered flavor, diagram 106 of FIG. 10. Table 6 below summarizes these results:TABLE 6WHAT PERCENTAGE OF THE PRESENT INVENTIONNON-NICOTINE INHALATION METHOD / DEVICEUSERS PREFER EACH OFFERED FLAVORANSWER CHOICESRESPONSESRESPONDENTSNever Going Bacco ™26.32%30(nicotine-free)Innocent Mint ™45.61%52An Apple A Day ™35.96%41Peach of Mind ™50.88%58Mango Forward ™38.60%44Total Respondents:114

[0047] FIG. 11 shows a bar diagram of results from a survey as to what percentage of the present invention non-nicotine inhalation method / device usage replaced nicotine smoking and / or nicotine vaping, diagram 107 of FIG. 11. Table 7 below summarizes these results:TABLE 7WHAT PERCENTAGE OF THE PRESENT INVENTION NON-NICOTINE INHALATION METHOD / DEVICE USAGE REPLACEDNICOTINE SMOKING AND / OR NICOTINE VAPINGANSWER CHOICESRESPONSESRESPONDENTS10% reduction15.79%1825% reduction13.16%15greater than 25% but less10.53%12than 50%50% or more14.91%17more than 80%14.04%16I have successfully quit, and31.58%36no longer smoke Cigarettes ornicotine vapor productsTOTAL114

[0048] These results show preference, efficacy and the unexpected results of the user reducing or eliminating withdrawal symptoms, as well as reducing or eliminating nicotine products that they had previously used. Whether these results are psychological, physical or a combination, the survey results are exceptional. In addition, the following conclusions are observed:

[0049] Consumer validation of this approach comes from the above Inhale Health Anti-Cigarette® Survey, in which: 88.6% of respondents reported they currently use Anti-Cigarette® to reduce their use of cigarettes or nicotine vape pens. 63.2% very much agreed that Anti-Cigarette® helped reduce their smoking or vaping. 53.5% stated Anti-Cigarette® provides craving and withdrawal relief equal to or better than nicotine replacement therapies (e.g., patches, gums). Notably, 31.6% of respondents reported complete cessation—they no longer use nicotine products at all. These results (31.6% reported quit rate) is actually equal or greater than the leading pharmaceutical treatments such as NRT (Nicotine Replacement Therapy). These pharmaceutical products / treatments such as Nicorette®, Nicoderm® products have been sold for decades. In large, randomized trials for NRT therapies, the absolute quit rate is about 10-17%, meaning most users still relapse. Real-world studies show smaller effects than clinical trials, with success rates often in the 10-30% range, influenced by adherence and follow-up. One population study found 10.4% of NRT users remained abstinent at 6 months, versus lower rates in those using no cessation method.

[0050] Flavor appeal was high, with top selections being Peach and Apple. what percentage of the present invention non-nicotine inhalation device usage replaced nicotine smoking and / or nicotine vaping Critically, all flavors are non-aversive, pleasant, and designed to distract the user's senses from nicotine cravings. This feature is central to the invention's function. Flavors tested and favored in the consumer study include:

[0051] Mango Forward™

[0052] An Apple A Day™

[0053] Innocent Mint™

[0054] Peach of Mind™

[0055] Never Going Bacco™ (a tobacco-free nostalgic flavor)Flavor Preference Stats (from Q20, N=114):

[0056] 45.6% selected Innocent Mint™

[0057] 38.6% selected Mango Forward™

[0058] 35.9% selected An Apple A Day™These flavors were rated highly not only for enjoyment but also for their role in managing cravings and emotional symptoms, such as irritability, restlessness, and anxiety-common during nicotine withdrawal.Survey highlights reinforcing effectiveness include:

[0059] 41.2% of users “very much agreed” that Anti-Cigarette® helped manage cravings.

[0060] 53.5% agreed it helped more than or equal to NRT products.

[0061] 31.6% of users reported they had quit smoking / vaping entirely using the device—a result virtually unheard of for non-nicotine products.

[0062] These findings validate that positive sensory input from pleasant flavors—rather than nicotine—can drive real behavioral change, a counterintuitive and non-obvious effect not predicted by prior art.

[0063] These outcomes underscore the unexpected and non-obvious effectiveness of pleasurable, non-harsh flavor profiles—a significant departure from traditional nicotine-cessation strategies that rely on either chemical substitution or aversive mimicry of tobacco.

Claims

1. A method for use by a nicotine-based product user to reduce or eliminate nicotine-based product consumption, which comprises:a) providing an inhaler device to a nicotine-based product user to reduce or eliminate nicotine-based product consumption, said inhaler device including:i) an inhaler having the functional components of a vape inhaler, including an inhaler nozzle, an air intake portal, a vapor generator mechanism, and a reservoir for material to be vaporized and inhaled;ii) material to be vaporized and inhaled, contained within said reservoir, said material including the following required constituents; i) glycerin, ii) propylene glycol, and iii) one or more flavorants selected for its pleasant characteristics selected from the group consisting of aroma, taste and combinations thereof, said material being nicotine-free; and,b) having said user activate said inhaler device and inhale vaporized nicotine-free formulation of said glycerin, propylene glycol and at least one said flavorant.

2. The method of claim 1 wherein said one or more flavorants are one or more natural, synthetic or mixed natural and synthetic flavorants selected from the group consisting of mango, mint, apple, peach and non-nicotine tobacco.

3. The method of claim 1 wherein said vapor generator mechanism is selected from the group consisting of a thermal vapor generator mechanism and a mechanical vapor generator mechanism, and said reservoir is a removable, replaceable cartridge.

4. The method of claim 3 wherein said vapor generator mechanism is a thermal vapor generator mechanism that includes a heating disc and a power source and an on-off control for activating and deactivating said heating disc.

5. The method of claim 3 wherein said vapor generator mechanism is a thermal vapor generator mechanism that includes a heating element and a power source and an on-off control for activating and deactivating said heating element.

6. The method of claim 5 wherein said vapor generator mechanism is a thermal vapor generator mechanism that includes a heating element and a rechargeable battery power source and an on-off control for activating and deactivating said heating element.

7. The method of claim 6 wherein said vapor generator mechanism rechargeable battery power source has an electrical recharging port and a connected signal light indicator that illuminates when the battery is fully charged.

8. The method of claim 3 wherein said vapor generator mechanism is a mechanical vapor generator mechanism that includes a nebulizer mechanism.

9. The method of claim 1 wherein said required constituent includes 10% to 79.9% by weight of glycerin based on 100% by weight of all required constituents, includes 20% to 89.9% by weight of propylene glycol based on 100% by weight of all required constituents and includes 0.1% to 65% by weight of flavorants based on 100% by weight of all required constituents.

10. The method of claim 1 wherein said required constituent includes preferred ranges of 35% to 75% by weight of glycerin based on 100% by weight of all required constituents, includes preferred ranges of 30% to 70% by weight of propylene glycol based on 100% by weight of all required constituents and includes preferred ranges of 1% to 25% by weight of flavorants based on 100% by weight of all required constituents.

11. The method of claim 1 wherein said reservoir further includes one or more botanical extracts selected from the group consisting of menthol, limonene and linalool.

12. The method of claim 1 wherein said reservoir further includes one or more bioactive additives selected from the group consisting of L-theanine, melatonin, caffeine and ascorbic acid.

13. A method for use by a nicotine-based product user to reduce or eliminate nicotine-based product consumption, which comprises:a) providing a disposable inhalation device to a nicotine-based product user to reduce or eliminate nicotine-based product consumption, said inhaler device includingi) a disposable inhaler having the functional components of a vape inhaler, including an inhaler nozzle, an air intake portal, a vapor generator mechanism, and a reservoir for material to be vaporized and inhaled;ii) material to be vaporized and inhaled, contained within said reservoir, said material including the following required constituents; i) glycerin, ii) propylene glycol, and iii) one or more flavorants selected from the group consisting of mango, mint, apple, peach and non-nicotine tobacco, and said material is nicotine-free, andb) having said user activate said inhaler device and inhale vaporized nicotine-free formulation of said glycerin, propylene glycol and at least one said flavorant.

14. The method of claim 13 wherein said one or more flavorants are one or more natural, synthetic or mixed natural and synthetic flavorants selected from the group consisting of mango, mint, apple, peach and non-nicotine tobacco.

15. The method of claim 13 wherein said vapor generator mechanism is selected from the group consisting of a thermal vapor generator mechanism and a mechanical vapor generator mechanism.

16. The method of claim 15 wherein said vapor generator mechanism is a thermal vapor generator mechanism that includes a heating disc and a power source and an on-off control for activating and deactivating said heating disc.

17. The method of claim 15 wherein said vapor generator mechanism is a thermal vapor generator mechanism that includes a heating element and a power source and an on-off control for activating and deactivating said heating element.

18. The method of claim 17 wherein said vapor generator mechanism is a thermal vapor generator mechanism that includes a heating element and a disposable battery power source and an on-off control for activating and deactivating said heating element.

19. The method of claim 13 wherein said reservoir further includes one or more botanical extracts selected from the group consisting of menthol, limonene and linalool.

20. The method of claim 13 wherein said reservoir further includes one or more bioactive additives selected from the group consisting of L-theanine, melatonin, caffeine and ascorbic acid.